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Florence–Utah Symposium corner: from genetics to
epigenetics of male infertility
The etiopathogenesis of testicular failure remains
unknown in about half of the clinical cases and it is
referred to as ‘idiopathic infertility’. Since the number of
genes involved in human spermatogenesis is possibly over
thousands and only a small fraction has been identified
and screened for mutations in infertile men (Nuti &
Krausz, 2008), it is likely that a substantial proportion of
‘idiopathic’ testicular failure is of genetic origin.
Several new strategies are now available for searching
spermatogenesis candidate genes based both on animal
models and on human studies, and a great selection was
showcased at the 3rd Florence-Utah Symposium (14–16
September, 2007). M.A. Handel presented data generated
in the context of the ReproGenomics Program which
deals with genome-wide mutagenesis in the mouse fol-
lowed by phenotype-driven identification of mutations
that cause infertility (http://reproductivegenomics.jax.org).
Proteomics and transcriptomics approaches also open
new horizons although their diffusion is limited by the
complexity and the high cost of such analyses (Platts
et al., 2007; Aitken & Baker, 2008; Oliva et al., 2008). In
recent years, case ⁄ control association studies dealing with
polymorphisms have become more and more popular
among human geneticists aiming to identify genetic ‘risk
factors’. However, despite the general enthusiasm towards
genetic variants, many in the field are often facing frus-
trating situations in which initial promising data are not
confirmed in later studies (Krausz & Giachini, 2007). A
rather unique example of successful replication of a previ-
ously reported genetic risk factor for impaired spermato-
genesis, on a substantially larger study population than
the original one, concerns the gr ⁄ gr deletion of the AZFc
region (Repping et al., 2003; Giachini et al., 2005, 2008).
The most frequently encountered biases responsible for
discrepancies between association studies are inadequate
sample size and inappropriate selection of patients and
controls. If the purpose of a case–control association
study is to detect the effect of a genetic variant on sper-
matogenesis, the appropriate control (‘disease-free’) group
should be represented by normozoospermic men rather
than men from the general population (7% are infertile)
or fertile men with unknown sperm count (10% of ‘fertile
men’ are severely oligozoospermic). Patients also should
be properly selected because the association between a
genetic risk factor and spermatogenic failure may be
weakened or lost by the inclusion of patients with known
causes of spermatogenic failure. Both the Repping et al.
(2003) and the Giachini et al. (2008) studies provided
strong support to the importance of ethnic and geo-
graphic matching of patients and controls (especially
relevant for Y chromosome variants).
The best approach to minimize the effect of confound-
ing factors would be the use of high-throughput geno-
typing (a rapid analysis of hundreds of thousands of
SNPs) in large study populations. Unfortunately, genome-
wide association studies are still lacking in the field of
andrology. There is an urgent need for this type of studies
not only to improve our knowledge of genetic risk factors
but also to provide a strategy that would accelerate the
identification of spermatogenesis candidate genes. The
review article by Rodriguez-Murillo and Greenberg (2008)
focuses on the strengths and weaknesses of association
studies and provides general indications ⁄ knowledge for
this type of genetic analysis.
The second review article by Carrell et al. (2008) deals
with male infertility related to sperm protamine abnor-
malities. Abnormal protamine replacement may lead to
generally diminished sperm quality, impaired fertilization
ability and increased DNA damage (Aoki et al., 2006).
The aetiology of sperm protamine abnormalities
(expressed as abnormal protamine 1 : protamine 2 ratio)
is largely unknown although some recent data appear to
provide previously unappreciated clues. The sequencing
of genes relevant to protamine expression in different lab-
oratories did not identify clear cut cause–effect mutations
so far. On the other hand the analysis of polymorphic
sites in the Contrin (YBX2) gene (a transcription factor
and translation repressor) revealed the presence of a few
SNPs possibly involved in abnormal protamine expression
(Hammoud et al., 2008). More studies are needed in this
specific area of research, while it would be especially use-
ful to combine analysis of multiple polymorphisms with
environmental factors. Besides mutational screening, the
authors discuss preliminary data generated by sperm
mRNA profiling that show consistent variation of the
sperm transcriptome between men with specific prot-
amine defects and controls. Finally, they focus on the link
between epigenome (histone retention and DNA methyla-
tion) and chromatin compaction defects. Especially
important is the hypothesis related to the role of ‘pro-
grammed’ histone retention in sperm chromatin
which should ensure specific marking of genes to be
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preferentially activated in early embryo development.
Abnormal protamine replacement could therefore affect
not only gene expression in mature sperm but also in
early embryo and ultimately affect embryo implantation
capacity.
These studies are in keeping with the notion that the
transcriptional machinery who governs the differentiation
programme of male germ cells is highly specialized
and intimately connected to unique epigenetic control
(Kimmins & Sassone-Corsi, 2005). The epigenetic pro-
gramme of male germ cells involves the generation of
highly specific histone variants, the histone-to-protamine
replacement process and the activation of distinct histone
modifications that are uncommon in somatic cells. In
addition, recent evidence indicates that the microRNA
pathway plays a critical role in the timing of post-meiotic
RNA translation. The chromatoid body of spermatids,
a unique organelle with remarkable structural and func-
tional features, seems to operate as a ‘nerve-centre’ for
the RNA metabolic pathway, in a fashion that is reminis-
cent of the P-bodies of somatic cells (Kotaja & Sassone-
Corsi, 2007).
The multiple fascinating facets of germ cell develop-
ment make it unique for biologists and clinicians. The
challenge of future studies lies on linking the interplay of
all molecular mechanisms to the various pathologies, spe-
cifically in the understanding of how genetic regulation
and epigenetic control operate in concert to insure the
fidelity and efficacy of the differentiation programme.
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